Lifeward (LFWD) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.10% |
| Dec 31, 2025 | 68.27% |
| Sep 30, 2025 | 69.99% |
| Jun 30, 2025 | 59.75% |
| Mar 31, 2025 | 58.92% |
| Dec 31, 2024 | 57.57% |
| Sep 30, 2024 | 51.12% |
| Jun 30, 2024 | 38.24% |
| Mar 31, 2024 | 32.53% |
| Dec 31, 2023 | -11.33% |
| Sep 30, 2023 | -21.77% |
| Jun 30, 2023 | -60.55% |
| Mar 31, 2023 | -55.05% |
| Dec 31, 2022 | -61.05% |
| Sep 30, 2022 | -53.63% |
| Jun 30, 2022 | -48.52% |
| Mar 31, 2022 | -110.45% |
| Dec 31, 2021 | -109.95% |
| Sep 30, 2021 | -159.34% |
| Jun 30, 2021 | -91.87% |
| Mar 31, 2021 | -96.99% |
| Dec 31, 2020 | -11.79% |
| Sep 30, 2020 | -11.77% |
| Jun 30, 2020 | 4.71% |
| Mar 31, 2020 | 1.03% |
| Dec 31, 2019 | 11.79% |
| Sep 30, 2019 | -18.07% |
| Jun 30, 2019 | -15.32% |
| Mar 31, 2019 | 25.93% |
| Dec 31, 2018 | 18.86% |
| Sep 30, 2018 | 40.75% |
| Jun 30, 2018 | 33.68% |
| Mar 31, 2018 | 37.98% |
| Dec 31, 2017 | 30.56% |
| Sep 30, 2017 | 35.28% |
| Jun 30, 2017 | -161.98% |
| Dec 31, 2016 | -38.77% |
| Sep 30, 2016 | -46.97% |